BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7574626)

  • 1. Effect of sodium hypochlorite exposure on infectivity of Cryptosporidium parvum oocysts for neonatal BALB/c mice.
    Fayer R
    Appl Environ Microbiol; 1995 Feb; 61(2):844-6. PubMed ID: 7574626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaseous disinfection of Cryptosporidium parvum oocysts.
    Fayer R; Graczyk TK; Cranfield MR; Trout JM
    Appl Environ Microbiol; 1996 Oct; 62(10):3908-9. PubMed ID: 8837451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utilization of sodium taurocholate in excystation of Cryptosporidium parvum and infection of tissue culture.
    Gold D; Stein B; Tzipori S
    J Parasitol; 2001 Oct; 87(5):997-1000. PubMed ID: 11695421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptosporidium parvum: treatment effects and the rate of decline in oocyst infectivity.
    Coulliette AD; Huffman DE; Slifko TR; Rose JB
    J Parasitol; 2006 Feb; 92(1):58-62. PubMed ID: 16629316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low temperatures on viability of Cryptosporidium parvum oocysts.
    Fayer R; Nerad T
    Appl Environ Microbiol; 1996 Apr; 62(4):1431-3. PubMed ID: 8919806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A NMRI suckling mouse model for the evaluation of infectivity of Cryptosporidium parvum oocysts.
    Xunde LI; Brasseur P
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(2):94-6. PubMed ID: 12567724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts.
    Castro-Hermida JA; Pors I; Méndez-Hermida F; Ares-Mazás E; Chartier C
    Vet J; 2006 Mar; 171(2):340-5. PubMed ID: 16490718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal-mouse infectivity of intact Cryptosporidium parvum oocysts isolated after optimized in vitro excystation.
    Hou L; Li X; Dunbar L; Moeller R; Palermo B; Atwill ER
    Appl Environ Microbiol; 2004 Jan; 70(1):642-6. PubMed ID: 14711704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral dosing of neonatal mice with sucrose reduces infection with Cryptosporidium parvum.
    Harp JA
    J Parasitol; 1999 Oct; 85(5):952-5. PubMed ID: 10577733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viability and infectivity of oocysts recovered from clams, Ruditapes philippinarum, experimentally contaminated with Cryptosporidium parvum.
    Freire-Santos F; Oteiza-López AM; Castro-Hermida JA; García-Martín O; Ares-Mazás ME
    Parasitol Res; 2001 Jun; 87(6):428-30. PubMed ID: 11411939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Cryptosporidium parvum development in various cell lines for screening in vitro drug testing.
    Siripanth C; Punpoowong B; Amarapal P; Thima N; Eampokalap B; Kaewkungwal J
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):540-6. PubMed ID: 15689063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectivity of Cryptosporidium parvum oocysts following cryopreservation.
    Kim HC; Healey MC
    J Parasitol; 2001 Oct; 87(5):1191-4. PubMed ID: 11695396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice.
    Yang S; Healey MC; Du C
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):141-5. PubMed ID: 8731022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of viability and infectivity of waterborne Cryptosporidium parvum oocysts.
    Uguen C; Brasseur P; Moreno-Sabater A; Favennec L; Ballet JJ
    J Eukaryot Microbiol; 1997; 44(6):73S. PubMed ID: 9508453
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the mixed-oxidant solution on infectivity of Cryptosporidium parvum oocysts in a neonatal mouse model].
    Sasahara T; Aoki M; Sekiguchi T; Takahashi A; Satoh Y; Kitasato H; Inoue M
    Kansenshogaku Zasshi; 2003 Feb; 77(2):75-82. PubMed ID: 12661082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of daily temperature fluctuation during the cool season on the infectivity of Cryptosporidium parvum.
    Li X; Atwill ER; Dunbar LA; Tate KW
    Appl Environ Microbiol; 2010 Feb; 76(4):989-93. PubMed ID: 20023095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of salinity, temperature and storage time on mouse experimental infection by Cryptosporidium parvum.
    Freire-Santos F; Oteiza-López AM; Vergara-Castiblanco CA; Ares-Mazás ME
    Vet Parasitol; 1999 Nov; 87(1):1-7. PubMed ID: 10628695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of common laboratory disinfectants on the infectivity of Cryptosporidium parvum oocysts in cell culture.
    Weir SC; Pokorny NJ; Carreno RA; Trevors JT; Lee H
    Appl Environ Microbiol; 2002 May; 68(5):2576-9. PubMed ID: 11976138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of amine-based disinfectant KENO™COX on the infectivity of Cryptosporidium parvum oocysts.
    Naciri M; Mancassola R; Fort G; Danneels B; Verhaeghe J
    Vet Parasitol; 2011 Jun; 179(1-3):43-9. PubMed ID: 21354705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.